Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation
Francesca Ricciardiello, Gang Yang, Roberta Palorini, Quanxiao Li, Marco Giampà, Fangyu Zhao, Lei You, Barbara La Ferla, Humberto De Vitto, Wenfang Guan, Jin Gu, Taiping Zhang, Yupei Zhao, Ferdinando Chiaradonna
Topics & Concepts
BiologyCancer researchDownregulation and upregulationGemcitabineCancerGrowth inhibitionCell growthPancreatic cancerCarcinogenesisProtein kinase BSignal transductionCell biologyGeneticsGenePancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and MetabolismPancreatic function and diabetes